Institutions / TCG Crossover Management, LLC
TCG Crossover Management, LLC
CIK 1839948 · Institution · as of Dec 31, 2025
Portfolio value
$3.02B
Positions
43
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 43 →
| Company | Value | % of portfolio |
|---|---|---|
| Abivax SA American Depositary Shares | $959.03M | 31.7% |
| Cogent Biosciences, Inc. | $208.44M | 6.9% |
| CG Oncology, Inc. | $152.39M | 5.0% |
| Tango Therapeutics, Inc. | $113.07M | 3.7% |
| Centessa Pharmaceuticals PLC | $107.20M | 3.5% |
| Dyne Therapeutics, Inc. | $90.27M | 3.0% |
| Rapt Therapeutics Inc | $87.47M | 2.9% |
| Tyra Biosciences, Inc. | $76.19M | 2.5% |
| Amylyx Pharmaceuticals, Inc. | $75.43M | 2.5% |
| Savara IncSVRA | $74.54M | 2.5% |
| Monte Rosa Therapeutics, Inc. | $72.48M | 2.4% |
| Ocular Therapeutix, Inc | $69.69M | 2.3% |
| Dianthus Therapeutics, Inc. | $69.09M | 2.3% |
| EyePoint, Inc. | $65.27M | 2.2% |
| Structure Therapeutics Inc.GPCR | $64.05M | 2.1% |
| Spyre Therapeutics, Inc. | $62.26M | 2.1% |
| Fulcrum Therapeutics, Inc. | $59.38M | 2.0% |
| Liquidia CorpLQDA | $58.98M | 2.0% |
| Biohaven Ltd. | $52.29M | 1.7% |
| Immunovant, Inc.IMVT | $42.22M | 1.4% |
| Kodiak Sciences Inc.KOD | $40.42M | 1.3% |
| Adc Therapeutics SA | $40.21M | 1.3% |
| Lb Pharmaceuticals IncLBRX | $38.84M | 1.3% |
| Xencor Inc | $37.54M | 1.2% |
| Revolution Medicines, Inc. | $34.77M | 1.2% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.